SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Thursday reported second-quarter earnings of $144.4 million.
The San Diego-based company said it had net income of $1.39 per share. Earnings, adjusted for stock option expense and costs related to mergers and acquisitions, were $2.85 per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $2.26 per share.
The biopharmaceutical company posted revenue of $959 million in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $901.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX
/Space/Rocket%20launching%20into%20space%20by%20BEST%20BACKGROUNDS%20via%20Shutterstock.jpg)
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)
/Close-up%20shot%20of%20Rivian%20R1T_%20Image%20by%20Trong%20Nguyen%20via%20%20Shutterstock_.jpg)
